Cargando…
Skin Toxicity as a Predictor of Survival in Metastatic Colorectal Cancer Patients Treated with Anti-EGFR: Fact or Fallacy?
SIMPLE SUMMARY: Targeted therapy and chemotherapy are the mainstays of treatment to improve the survival of patients with metastatic colorectal cancer (mCRC). When RAS and BRAF genes are normal, a molecular target treatment with an anti-EGFR antagonist is prescribed. Anti-EGFR antagonists induce ski...
Autores principales: | Chiang, Ting-Yu, Hsu, Hung-Chih, Chern, Yih-Jong, Liao, Chun-Kai, Hsu, Yu-Jen, Tsai, Wen-Sy, Hsieh, Pao-Shiu, Lin, Yu-Fen, Lee, Hsiu-Lan, You, Jeng-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046585/ https://www.ncbi.nlm.nih.gov/pubmed/36980549 http://dx.doi.org/10.3390/cancers15061663 |
Ejemplares similares
-
Advantage of laparoscopy surgery for elderly colorectal cancer patients without compromising oncologic outcome
por: Chern, Yih-Jong, et al.
Publicado: (2020) -
Prognostic value of regional lymph node involvement in patients with metastatic colorectal cancer: palliative versus curative resection
por: Kuo, Ya-Ting, et al.
Publicado: (2021) -
Facts and Fallacies in the Debate on Glyphosate Toxicity
por: Mesnage, Robin, et al.
Publicado: (2017) -
The risk factors of local recurrence and distant metastasis on pT1/T2N0 mid-low rectal cancer after total mesorectal excision
por: Lai, I-Li, et al.
Publicado: (2021) -
Potential short-term outcome advantage of low vs. high ligation of inferior mesenteric artery for sigmoid and rectal cancer: propensity score matching analysis
por: Hsu, Chia-Chen, et al.
Publicado: (2023)